Budigalimab
CAS: 2098225-93-3
Ref. TM-T76936
| 1mg | 206.00 € | ||
| 5mg | 527.00 € | ||
| 10mg | 846.00 € | ||
| 25mg | 1,257.00 € | ||
| 50mg | 1,632.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Product Information
Name:
Budigalimab
Synonyms:
- PR1648817
- PR 1648817
- ABBV181
- ABBV 181
Description:
Budigalimab (ABBV 181) is a humanized monoclonal antibody targeting PD-1 with potential antitumor activity.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Purity:
95% - 95%
Color/Form:
Liquid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T76936 Budigalimab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
